CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
3.2455
0.72%
Market Trading Hours* (UTC) Open now
Closes on Monday at 16:30

Mon - Fri: 08:00 - 16:30

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Ownership
Trading сonditions
Spread 0.0130
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.02526 %
Charges from full value of position ($-4.80)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.02526%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003343 %
Charges from full value of position ($0.64)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003343%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency GBP
Margin 5%
Stock exchange United Kingdom of Great Britain and Northern Ireland
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 3.272
Open* 3.252
1-Year Change* 0.03%
Day's Range* 3.2375 - 3.271
52 wk Range N/A
Average Volume (10 days) N/A
Average Volume (3 months) N/A
Market Cap N/A
P/E Ratio N/A
Shares Outstanding N/A
Revenue N/A
EPS N/A
Dividend (Yield %) N/A
Beta N/A
Next Earnings Date N/A

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 23, 2024 3.2710 0.1325 4.22% 3.1385 3.2950 3.1385
Feb 22, 2024 3.2595 0.0250 0.77% 3.2345 3.2740 3.2345
Feb 21, 2024 3.2360 0.0285 0.89% 3.2075 3.2550 3.1485
Feb 20, 2024 3.2285 0.0100 0.31% 3.2185 3.2535 3.1425
Feb 19, 2024 3.2205 -0.0195 -0.60% 3.2400 3.2440 3.2120
Feb 16, 2024 3.2200 0.1250 4.04% 3.0950 3.2560 3.0950
Feb 15, 2024 3.1945 0.0760 2.44% 3.1185 3.2080 3.0810
Feb 14, 2024 3.1470 -0.0140 -0.44% 3.1610 3.1830 3.1470
Feb 13, 2024 3.1695 0.0860 2.79% 3.0835 3.1940 3.0835
Feb 12, 2024 3.1860 0.0205 0.65% 3.1655 3.2075 3.1585
Feb 9, 2024 3.1655 0.0180 0.57% 3.1475 3.2190 3.1475
Feb 8, 2024 3.2275 -0.0345 -1.06% 3.2620 3.2910 3.2245
Feb 7, 2024 3.2500 -0.0185 -0.57% 3.2685 3.2890 3.2500
Feb 6, 2024 3.2500 -0.0105 -0.32% 3.2605 3.3000 3.2500
Feb 5, 2024 3.2680 0.0305 0.94% 3.2375 3.2970 3.2365
Feb 2, 2024 3.2400 -0.0260 -0.80% 3.2660 3.2785 3.2400
Feb 1, 2024 3.2380 0.0525 1.65% 3.1855 3.2430 3.1705
Jan 31, 2024 3.1960 -0.0145 -0.45% 3.2105 3.2485 3.1890
Jan 30, 2024 3.1975 0.0155 0.49% 3.1820 3.2445 3.1820
Jan 29, 2024 3.1645 -0.0045 -0.14% 3.1690 3.2200 3.1615

Haleon PLC Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019
Total revenue 10858 9545 9892 8480
Revenue 10858 9545 9892 8480
Cost of Revenue, Total 4133 3561 3794 3249
Gross Profit 6725 5984 6098 5231
Total Operating Expense 9241 7872 8265 7580
Selling/General/Admin. Expenses, Total 3943 3567 3811 3349
Research & Development 303 256 296 267
Unusual Expense (Income) 818 519 576 698
Other Operating Expenses, Total -2 -31 -212 17
Operating Income 1617 1673 1627 900
Interest Income (Expense), Net Non-Operating 5 -34 -31 -10
Other, Net -4 -3 -5 -4
Net Income Before Taxes 1618 1636 1591 886
Net Income After Taxes 1119 1439 1181 687
Minority Interest -59 -49 -36 -32
Net Income Before Extra. Items 1060 1390 1145 655
Net Income 1060 1390 1145 655
Income Available to Common Excl. Extra. Items 1060 1390 1145 655
Income Available to Common Incl. Extra. Items 1060 1390 1145 655
Diluted Net Income 1060 1390 1145 655
Diluted Weighted Average Shares 9239 9234.57 9234.57 9234.57
Diluted EPS Excluding Extraordinary Items 0.11473 0.15052 0.12399 0.07093
Dividends per Share - Common Stock Primary Issue 0 0 0
Diluted Normalized EPS 0.17596 0.19843 0.17431 0.13029
Depreciation / Amortization 46
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 2752 2986 2778 2892 2561
Revenue 2752 2986 2778 2892 2561
Cost of Revenue, Total 1039 1146 1224 1068 956
Gross Profit 1713 1840 1554 1824 1605
Total Operating Expense 2238 2359 2422 2323 2127
Selling/General/Admin. Expenses, Total 1088 1071 1046 1027 985
Research & Development 66 75 82 84 71
Unusual Expense (Income) 53 53 70 146 116
Other Operating Expenses, Total -8 3 -2 -1
Operating Income 514 627 356 569 434
Interest Income (Expense), Net Non-Operating -96 -85 -97 -74 -35
Net Income Before Taxes 418 542 259 495 399
Net Income After Taxes 315 415 210 365 187
Minority Interest -17 -26 -12 -20 -13
Net Income Before Extra. Items 298 389 198 345 174
Net Income 298 389 198 345 174
Income Available to Common Excl. Extra. Items 298 389 198 345 174
Income Available to Common Incl. Extra. Items 298 389 198 345 174
Diluted Net Income 298 389 198 345 174
Diluted Weighted Average Shares 9266.1 9261.9 9252.28 9234.57 9234.57
Diluted EPS Excluding Extraordinary Items 0.03216 0.042 0.0214 0.03736 0.01884
Dividends per Share - Common Stock Primary Issue 0.024 0 0 0
Diluted Normalized EPS 0.03647 0.04638 0.02753 0.04902 0.02473
Depreciation / Amortization 11
  • Annual
  • Quarterly
2022 2021 2020 2019
Total Current Assets 4059 5251 5008 5811
Cash and Short Term Investments 606 347 281 323
Cash 346 280 322
Cash & Equivalents 606 1 1 1
Total Receivables, Net 1871 3825 3590 3994
Accounts Receivable - Trade, Net 1487 1319 1349 1399
Total Inventory 1348 951 949 1211
Prepaid Expenses 106 56 61 29
Other Current Assets, Total 128 72 127 254
Total Assets 34815 34451 34130 35711
Property/Plant/Equipment, Total - Net 1899 1662 1602 1621
Property/Plant/Equipment, Total - Gross 3113 2804 2794 2762
Accumulated Depreciation, Total -1214 -1142 -1192 -1141
Goodwill, Net 8396 8246 8265 8171
Intangibles, Net 20040 18949 18953 19841
Other Long Term Assets, Total 421 343 302 267
Total Current Liabilities 4370 4238 4014 4269
Accounts Payable 1835 1369 1340 1201
Accrued Expenses 1763 1412 1430 1436
Notes Payable/Short Term Debt 393 874 348 481
Current Port. of LT Debt/Capital Leases 44 30 34 40
Other Current Liabilities, Total 335 553 862 1111
Total Liabilities 18484 8096 8018 8390
Total Long Term Debt 10003 87 105 121
Capital Lease Obligations 117 87 105 121
Deferred Income Tax 3601 3357 3373 3514
Minority Interest 126 125 111 91
Other Liabilities, Total 384 289 415 395
Total Equity 16331 26355 26112 27321
Common Stock 92 1 1 1
Additional Paid-In Capital 0 0 0 20842
Retained Earnings (Accumulated Deficit) 15193 26354 26111 6478
Total Liabilities & Shareholders’ Equity 34815 34451 34130 35711
Total Common Shares Outstanding 9234.57 9234.57 9234.57 9234.57
Long Term Debt 9886
Other Equity, Total 1046
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 4202 4059
Cash and Short Term Investments 490 684
Cash & Equivalents 490 684
Total Receivables, Net 2195 1977
Total Inventory 1501 1348
Other Current Assets, Total 16 50
Total Assets 34164 34815
Property/Plant/Equipment, Total - Net 1847 1899
Intangibles, Net 27674 28436
Other Long Term Assets, Total 441 421
Total Current Liabilities 4987 4370
Payable/Accrued 3510 3621
Notes Payable/Short Term Debt 503 393
Current Port. of LT Debt/Capital Leases 594 44
Other Current Liabilities, Total 380 312
Total Liabilities 17714 18484
Total Long Term Debt 8768 10003
Long Term Debt 8663 9886
Capital Lease Obligations 105 117
Deferred Income Tax 3439 3601
Minority Interest 117 126
Other Liabilities, Total 403 384
Total Equity 16450 16331
Common Stock 92 92
Additional Paid-In Capital 0
Retained Earnings (Accumulated Deficit) 15697 15193
Total Liabilities & Shareholders’ Equity 34164 34815
Total Common Shares Outstanding 9234.57 9234.57
Other Equity, Total 661 1046
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Pfizer Inc Corporation 25.6 2364050902 0 2023-10-05 LOW
GSK plc Corporation 7.9931 738132722 -270000000 2023-10-10 LOW
Glaxo Group, Ltd. Holding Company 2.845 262727073 262727073 2023-05-12 LOW
Dodge & Cox Investment Advisor/Hedge Fund 2.015 186075089 10797900 2023-10-01 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 1.849 170745042 1286013 2023-08-08 LOW
MFS Investment Management Investment Advisor/Hedge Fund 1.6213 149724220 4341932 2023-10-01 LOW
Franklin Mutual Advisers, LLC Investment Advisor/Hedge Fund 1.5694 144927104 71121513 2023-07-28 LOW
Harding Loevner LP Investment Advisor 1.422 131314378 0 2023-08-08 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 1.2803 118233486 4467279 2023-10-01 LOW
First Eagle Investment Management, L.L.C. Investment Advisor/Hedge Fund 1.2299 113579912 748747 2023-08-08 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 1.2121 111935798 -9472200 2023-10-01 LOW
Wellington Management Company, LLP Investment Advisor/Hedge Fund 0.9592 88579943 351772 2023-10-01 LOW
BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund 0.6191 57173526 4666727 2023-10-01 LOW
Nuveen LLC Pension Fund 0.5766 53249103 -182333 2023-08-08 LOW
Legal & General Investment Management Ltd. Investment Advisor/Hedge Fund 0.5285 48806977 -242205 2023-10-01 LOW
BlackRock Advisors (UK) Limited Investment Advisor/Hedge Fund 0.5152 47580920 -17672383 2023-10-01 LOW
Invesco Advisers, Inc. Investment Advisor 0.4954 45744588 -63332 2023-10-01 LOW
Columbia Threadneedle Investments (UK) Investment Advisor/Hedge Fund 0.4218 38952564 -1678264 2023-08-08 LOW
Liontrust Investment Partners LLP Investment Advisor 0.3875 35783647 -680050 2023-07-28 LOW
State Street Global Advisors (UK) Ltd. Investment Advisor/Hedge Fund 0.3681 33988721 0 2023-10-01 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Haleon PLC

Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom. --FAKE
Industry: Pharmaceuticals (NEC)

Building 5, First Floor
The Heights
BRENTFORD
MIDDLESEX KT13 0NY
GB

Income Statement

  • Annual
  • Quarterly

News

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

UK Bank Earnings: What to expect from Lloyds, Barclays and HSBC?

UK banks will be in the spotlight in the week ahead as the European earnings season continues

16:38, 16 February 2024

Is Big Tech behind the apparent bull market rally?

While the Magnificent Seven have dominated market momentum in recent months, it’s not true that they are the sole drivers of the recent rally in equity markets.

16:05, 8 February 2024

US Earnings Week Ahead: Walt Disney, Uber, and Pepsi Co.

The last of the Magnificent Seven have reported, delivering mixed results. Meanwhile, according to FactSet, the S&P 500 is set for negative earnings growth for Q4, with estimates for the next quarter also downgraded.

16:24, 2 February 2024

Bank of England preview: will updated projections show more cuts are expected in 2024?

Markets have no doubt that the BoE will keep its rate unchanged

15:43, 31 January 2024

Meta Platforms Q4 earnings forecast to surge on solid ad revenues

Meta Platforms (META) reports its Q4 results after Wall Street’s closing bell on February 1, 2024. We preview what to expect from the results and analyse the stock’s technicals.

15:33, 31 January 2024

Federal Reserve meeting preview: strong data is making it hard to justify cutting rates

Markets expect the Fed to keep rates unchanged as strong economic data continues

11:30, 30 January 2024

People also watch

US100

17,967.10 Price
+0.250% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0039%
Overnight fee time 22:00 (UTC)
Spread 1.8

XRP/USD

0.54 Price
-0.970% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

Oil - Crude

76.82 Price
+0.360% 1D Chg, %
Long position overnight fee 0.0165%
Short position overnight fee -0.0384%
Overnight fee time 22:00 (UTC)
Spread 0.030

BTC/USD

51,999.50 Price
-0.080% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading